The WHO classified the ongoing Bundibugyo ebolavirus outbreak in the Democratic Republic of Congo as a public health emergency of international concern (PHEIC). The escalation reflects laboratory-confirmed cases and a high positivity rate among samples, alongside reports of suspected clusters and cross-border spread signals into Uganda. WHO cited concerns that the outbreak may be larger than currently detected and emphasized the lack of approved vaccines or antivirals for this virus. The PHEIC designation increases international attention and coordination for surveillance, diagnostics, and potential countermeasure deployment. For biotech and healthcare supply chains, the designation is a forcing function for readiness—especially for partners working on diagnostics and investigational therapeutics in filovirus systems.